$PDLI PDL BIOPHARMA, INC. Insider Trading
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in PDL BIOPHARMA, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in PDL BIOPHARMA, INC. for free.
CIK Number: 0000882104
IRS Number: 943023969
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: PDLI
Company Address: 59 DAMONTE RANCH PARKWAY SUITE B-375 RENO 89521
Former name: PROTEIN DESIGN LABS INC/DE, date of change: 1993-03-28
Market Capitalization: $367.50M
Prev close: $2.21
Average Daily Volume: 2,845,720
Days Low: $2.15
Year Low: $1.93
Year High: $3.84
PDL BIOPHARMA, INC. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 04 2021 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.50 | 6,325,213 | 15,813,033 | 23,783,273 | 17.5 M to 23.8 M (+36.23 %) |
Dec 31 2020 | PDLI | PDL BIOPHARMA, INC ... | GRYSKA DAVID W | Director | Sell | S | 2.74 | 20,000 | 54,800 | 1,387 | 21.4 K to 1.4 K (-93.51 %) |
Dec 29 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.69 | 268,600 | 722,534 | 17,458,060 | 17.2 M to 17.5 M (+1.56 %) |
Dec 29 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.70 | 235,000 | 634,500 | 17,189,460 | 17 M to 17.2 M (+1.39 %) |
Dec 29 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.65 | 128,000 | 339,200 | 16,954,460 | 16.8 M to 17 M (+0.76 %) |
Dec 23 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.60 | 485,000 | 1,261,000 | 16,826,460 | 16.3 M to 16.8 M (+2.97 %) |
Dec 23 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.59 | 850,000 | 2,201,500 | 16,341,460 | 15.5 M to 16.3 M (+5.49 %) |
Dec 23 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.63 | 230,000 | 604,900 | 15,491,460 | 15.3 M to 15.5 M (+1.51 %) |
Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.61 | 277,934 | 724,574 | 200,000 | 477.9 K to 200 K (-58.15 %) |
Dec 22 2020 | PDLI | PDL BIOPHARMA, INC ... | MCLAUGHLIN JOHN PETER | Director | Sell | S | 2.62 | 50,000 | 131,200 | 477,934 | 527.9 K to 477.9 K (-9.47 %) |
Dec 18 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.61 | 398,000 | 1,038,780 | 15,261,460 | 14.9 M to 15.3 M (+2.68 %) |
Dec 18 2020 | PDLI | PDL BIOPHARMA, INC ... | Silver Point Capital L.P. | 10% Owner | Buy | P | 2.58 | 1,350,000 | 3,483,000 | 14,863,460 | 13.5 M to 14.9 M (+9.99 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Monnet Dominique | President and CEO | Sell | S | 2.60 | 500,000 | 1,300,000 | 734,921 | 1.2 M to 734.9 K (-40.49 %) |
Dec 17 2020 | PDLI | PDL BIOPHARMA, INC ... | Stone Christopher Lewis | VP, Gen. Counsel & ... | Sell | S | 2.56 | 200,000 | 512,000 | 405,559 | 605.6 K to 405.6 K (-33.03 %) |